Back to search

Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients

Data up to Jan 2025

Published2007
Citations56
References35

Total Citations Per Year

Abstract

References (35)

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

1997 • 1,783 citations

A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

2005 • 1,333 citations

Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902

2001 • 1,091 citations

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

2000 • 927 citations

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

2002 • 711 citations

From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

2003 • 619 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

1998 • 581 citations

Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells

1993 • 514 citations

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

2002 • 429 citations

Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients

2000 • 387 citations

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

1999 • 308 citations

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

1999 • 272 citations

Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.

1998 • 228 citations

Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up

1991 • 212 citations

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

2005 • 174 citations

Primary chemotherapy in operable breast cancer.

1996 • 80 citations

Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.

2003 • 80 citations

Preoperative/neoadjuvant medical therapy for early breast cancer

2001 • 75 citations

Minimal Residual Disease in Gastric Cancer: Evidence of an Independent Prognostic Relevance of Urokinase Receptor Expression by Disseminated Tumor Cells in the Bone Marrow

2002 • 74 citations

The Prognostic Value of Isolated Tumor Cells in Bone Marrow in Breast Cancer Patients

2004 • 71 citations

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

2004 • 68 citations

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

2005 • 68 citations

Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact

2003 • 52 citations

Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

2001 • 52 citations

The Efficacy of Neoadjuvant Chemotherapy Compared to Postoperative Therapy in the Treatment of Locally Advanced Breast Cancer

1998 • 45 citations

Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0)

2003 • 23 citations

Image analysis systems for the detection of disseminated breast cancer cells on bone‐marrow cytospins

2005 • 16 citations

Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer

2001 • 14 citations

Minimal Residual Disease in Breast Cancer and Gynecological Malignancies: Phenotype and Clinical Relevance

2003 • 13 citations

Prognostische Bedeutung des Tumorzellnachweises im Knochenmark im Vergleich zum Nodalstatus beim primären Mammakarzinom

1997 • 11 citations

Is Primary Chemotherapy Useful for All Patients with Primary Invasive Breast Cancer?

1998 • 9 citations

Disseminated melanoma cells in blood and bone marrow. Significance and detection by potential tumor markers

2001 • 4 citations

Disseminierte Melanomzellen in Blut und Knochenmark Bedeutung und Nachweis durch potenzielle Tumormarker

2001 • 2 citations

Disseminierte Melanomzellen in Blut und Knochenmark

2001 • 2 citations

Cited By (0)

Loading...
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer… (2007) – Breast Cancer Research and Treatment | Metascience Observatory Explorer